Akzo Nobel India has announced that Imperial Chemical Industries Limited (ICIL), a public shareholder, has sold 40,97,025 equity shares, representing approximately 9% of Akzo Nobel India’s total paid-up capital. The sale was executed through a block deal on the National Stock Exchange of India Limited on December 17, 2025. Following this transaction, ICIL no longer holds any equity shares in the company.
Significant Stake Change
A notable shift in Akzo Nobel India’s shareholder structure has occurred, with Imperial Chemical Industries Limited (ICIL) divesting a substantial portion of its holdings. On December 17, 2025, ICIL sold 40,97,025 equity shares in Akzo Nobel India.
Financial Details of the Transaction
The aggregate consideration from the block deal amounted to Rs. 1296.09 crore (rounded off). This sale represents approximately 9% of the total paid-up capital of Akzo Nobel India, marking a significant transaction in the company’s stock.
ICIL’s Position Post-Transaction
Following the completion of the block deal, Imperial Chemical Industries Limited (ICIL) no longer holds any equity stake in Akzo Nobel India. The shares were sold via open market transaction through Block Deal on the National Stock Exchange.
Source: BSE
